Menu
Back to Journals » International Journal of Nanomedicine » Volume 17
Comparative Assessment of the Apoptotic Potential of Silver Nanoparticles Synthesized by Bacillus Tequilensis and Calocybe Indica in MDA-MB-231 Human Breast Cancer Cells: Targeting p53 for Anticancer Therapy [Corrigendum]
Authors Gurunathan S , Park JH, Han JW, Kim J
Received 2 November 2022
Accepted for publication 2 November 2022
Published 4 November 2022 Volume 2022:17 Pages 5207—5208
Gurunathan S, Park JH, Han JW, Kim J. Int J Nanomedicine. 2015;10(1):4203–4223.
It was bought to the authors attention that there are errors in Figure 14 on page 4218. The DAPI images, panels B-AgNPs + PFT-α and F-AgNPs + PFT-α were duplicated. The error was introduced during the article revision process and went unnoticed. The authors wish to apologize for this oversight and for any inconveniences caused.
The correct Figure 14 is as follows.
 |
Figure 14 PFT-α inhibits B-AgNPs- and F-AgNPs-induced apoptosis in a p53-dependent manner. Abbreviations: B-AgNPs, bacterium-derived AgNPs; DAPI, 4′,6-diamidino-2-phenylindole; F-AgNPs, fungus-derived AgNPs; IC50, half-maximal inhibitory concentration; PFT- α, pifithrin-alpha; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling. Notes: Cells were pretreated with PFT-α (10 μM) for 1 hour and then incubated with respective IC50 concentrations of B-AgNPs or F-AgNPs for 24 hours. Apoptosis was measured using the TUNEL assay. |
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.